| scholarly article | Q13442814 |
| P2093 | author name string | C. Schneider | |
| K-H Kuck | |||
| K. Jaquet | |||
| K. Krause | |||
| M. W. Bergmann | |||
| A. Ujeyl | |||
| P2860 | cites work | Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 |
| Regenerating the heart | Q22251075 | ||
| Evidence for cardiomyocyte renewal in humans | Q24594522 | ||
| Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells | Q24672061 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction | Q30968626 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy | Q33546217 | ||
| Unchain my heart: the scientific foundations of cardiac repair | Q33683767 | ||
| Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies | Q34186486 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Stem cell niches in the adult mouse heart | Q34657903 | ||
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology | Q34830023 | ||
| Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. | Q37018900 | ||
| Cell therapy of acute myocardial infarction: open questions | Q37362083 | ||
| Generation of functional ventricular heart muscle from mouse ventricular progenitor cells | Q39786941 | ||
| Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy | Q42635770 | ||
| Intramyocardial transplantation of bone marrow-derived stem cells: ultrasonic strain rate imaging in a model of hibernating myocardium | Q43420246 | ||
| Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study | Q44339304 | ||
| Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure | Q44411377 | ||
| Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int | Q61942700 | ||
| Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies | Q79826696 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | German | Q188 |
| P921 | main subject | ischemic cardiomyopathy | Q12075432 |
| P304 | page(s) | 317-323 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | Herz | Q2143725 |
| P478 | volume | 35 |
| Q82451686 | Bibliography—Editors’ selection of current word literature |
| Q82085577 | Clinical perspectives of heart muscle regeneration by stem cells: a future-oriented epilogue |
| Q35788189 | Mast cell tryptase, a still enigmatic enzyme |
| Q85240790 | Stem and progenitor cell-based therapy approaches: current developments on treatment of acute myocardial infarction and chronic ischemic cardiomyopathy |
Search more.